Podcasts about chief medical officers

In this episode, Ije Akunyili, MD, MBA, MPA, FACEP, Chief Medical Officer at Jersey City Medical Center, an RWJBarnabas Health facility, joins the podcast to discuss building a mortality and safety council, advancing women's health initiatives, and expanding partnerships to strengthen care delivery. She also shares how health systems can manage rising patient volumes while maintaining quality and safety.

The Non-Market Reality of Healthcare Carrier Marketplaces with Dr. Jacob Asher. In this episode of Relentlessly Seeking Value, host Stacey Richter introduces the 'No Market' series focused on the healthcare sector's lack of competitive market dynamics, which affects cost and quality.  The episode features a conversation with Dr. Jacob Asher, who has extensive experience as a Chief Medical Officer at major healthcare plans. They discuss the stagnant nature of commercial carrier marketplaces, particularly in California, and the various factors contributing to this stasis, including employer inertia, the influence of employee benefit consultants, and the strategic focus of carriers on Medicare Advantage over commercial business.  They also explore how carriers' dependence on existing provider networks and contractual negotiations based on member volumes contribute to a lack of meaningful competition. The episode highlights the challenges faced by plans attempting to innovate or differentiate on quality and the systemic issues that perpetuate the current equilibrium. === LINKS ===

In this episode, host Sandy Vance chats with Dr. Sean Kelly, the Chief Medical Officer and the SVP of Customer Healthcare Strategy at Imprivata. Together, they unpack how healthcare organizations can strengthen cybersecurity without slowing clinicians down—exploring everything from mobile device security and passwordless authentication to adaptive authentication, risky user behaviors, and the very real implications for patient safety, workflow efficiency, and ROI for healthcare leaders.In this episode, they talk about:How cybersecurity can be improvedThe impact that Imprivata has on clinicians Why multi-factor authentication systems aren't more prevalent in the healthcare industryThe risky behaviors that open up organizations to security risksThe different things that Imprivata offers organizationsThe risks of patient harm in cybersecurity and privacyAdvice for CIOs or CFOs: workflow implications, security compliance, security and efficiency ROI, and financial valueAdaptive authentication at ImprivataA Little About Sean:Dr. Sean Kelly brings a uniquely well-rounded perspective to healthcare, shaped by a career that spans emergency medicine, healthcare leadership, technology, teaching, and entrepreneurship. An emergency physician at Beth Israel Lahey Health in Boston and an Assistant Clinical Professor of Emergency Medicine at Harvard Medical School, he is also the Chief Medical Officer and SVP of Customer Healthcare Strategy at Imprivata, where he helps guide product vision, go-to-market strategy, and customer experience after more than a decade with the company from startup through IPO and private equity ownership. He has led high-performing teams in both clinical and executive settings, contributed to care delivery improvements impacting millions of patients, published widely in emergency medicine and medical education, and earned multiple teaching awards. His background includes training at Harvard College, UMass Medical School, and Vanderbilt University, co-founding a concierge medical practice on Martha's Vineyard, international teaching and humanitarian work, and service in roles ranging from hospital administration to disaster relief—all grounded in a deep commitment to learning, mentorship, and collaboration.

In this episode, Ije Akunyili, MD, MBA, MPA, FACEP, Chief Medical Officer at Jersey City Medical Center, an RWJBarnabas Health facility, joins the podcast to discuss building a mortality and safety council, advancing women's health initiatives, and expanding partnerships to strengthen care delivery. She also shares how health systems can manage rising patient volumes while maintaining quality and safety.

(February 18, 2026) Citing fire risk, L.A. city may get more power to remove hillside homeless encampments. Venezuela’s oil industry is in ruins… reviving it won’t be easy. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about intermittent fasting, sex drive and testosterone, AI stethoscopes, and Norovirus at the Winter Olympics. See omnystudio.com/listener for privacy information.

In this final episode of the Progesterone Promise series, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, breaks down one of the most misunderstood hormones in women's health: progesterone. Progesterone is not “good” or “bad.” It's contextual. In today's world of quick sound bites and social media medicine, hormones are often reduced to oversimplified claims like “progesterone fixes anxiety” or “progesterone causes breast cancer.” The truth? It depends on your body, your stress levels, your liver health, your inflammation, your delivery method, and whether you're using bioidentical progesterone or synthetic progestins.   Citations: 1. Oral Progesterone → First-Pass Metabolism & Allopregnanolone Claim: Oral micronized progesterone undergoes significant hepatic first-pass metabolism, increasing neuroactive metabolites (especially allopregnanolone), which positively modulate GABA-A receptors and produce sedative/anxiolytic effects. Core Evidence: Simon et al., 1993; de Lignières et al., 1995; Freeman et al., 1990 — Oral progesterone produces measurable neuroactive metabolites. Paul & Purdy, 1992; Rupprecht et al., 2001 — Allopregnanolone enhances GABA-A receptor activity. Supports: Sedation variability by route • Neurosteroid generation • GABA-A modulation 2. Sulfation vs 5α-Reduction → Opposing Neurologic Effects Claim: Progesterone metabolites can produce calming (5α-reduced) or excitatory (sulfated) neurologic effects depending on enzyme routing. Core Evidence: Majewska et al., 1990 — Pregnenolone sulfate negatively modulates GABA-A. Wu et al., 1991 — Sulfated neurosteroids enhance NMDA signaling. Schumacher et al., 2007; Reddy, 2010 — Pathway reviews of sulfation vs 5α-reduction. Supports: Reverse responding hypothesis • Divergent neurologic experiences • Enzyme-dependent effects 3. Stress & Enzyme Modulation Claim: Chronic stress alters HPA axis tone and hepatic enzyme expression, influencing steroid metabolism balance. Core Evidence: McEwen, 1998 — Allostatic load model. Charmandari et al., 2005 — Cortisol's systemic regulatory effects. Zanger & Schwab, 2013; Gibson & Skett, 2001 — Stress alters cytochrome P450 expression. Supports: Stress-biased metabolism • Context-dependent hormone response 4. Breast Tissue Signaling & Context Claim: Progesterone influences mammary differentiation and interacts with estrogen signaling in context-dependent ways. Core Evidence: Brisken & O'Malley, 2010 — Progesterone receptor biology in breast tissue. Beleut et al., 2010 — RANKL mediates progesterone-driven proliferation. Hofseth et al., 1999 — PR-ER signaling interaction. Stanczyk & Bhavnani, 2014 — Natural vs synthetic differences in breast effects. Supports: Lobuloalveolar differentiation • RANKL pathway • Context-dependent proliferation 5. Synthetic Progestins vs Bioidentical Progesterone Claim: Synthetic progestins differ structurally and bind off-target receptors, producing distinct tissue effects. Core Evidence: Stanczyk et al., 2013 — Receptor binding differences. Sitruk-Ware, 2004 — Biologic comparisons. Chlebowski et al., 2003 (WHI) — Breast cancer signal with CEE + MPA. Supports: Structural divergence • Receptor-level differences • WHI clarification 6. Route of Delivery Differences Claim: Oral, vaginal, transdermal, and sublingual progesterone produce distinct pharmacokinetic profiles and tissue targeting. Core Evidence: Simon, 1995 — Oral vs vaginal PK comparison. Cicinelli et al., 2000 — “First uterine pass effect.” Wren et al., 2003 — Route-dependent systemic levels. Supports: Uterine targeting • Neurosteroid variability • Sedation differences 7. Progesterone, PMS & Migraine Claim: Neurosteroid fluctuations influence GABAergic tone and may contribute to PMS and migraine susceptibility. Core Evidence: Backstrom et al., 2011 — Allopregnanolone fluctuations in PMS. Reddy & Rogawski, 2002 — Neurosteroids and seizure threshold. Martin & Behbehani, 2001 — Hormonal fluctuations and migraine. Supports: Luteal neurosteroid shifts • GABA instability • Migraine association   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about intermittent fasting, sex drive and testosterone, AI stethoscopes, and Norovirus at the Winter Olympics. See omnystudio.com/listener for privacy information.

Dr. David Kirk, Chief Medical Officer at Regard, discusses the role and benefits of real-time clinical AI to help clinicians navigate patient charts and find critical information to prevent medication management errors and misdiagnoses. The Regard platform can also generate proactive documentation, allowing physicians to complete their documentation more accurately and efficiently, reducing note-bloat and the need for after-hours charting. One key goal of using AI is to free physicians to spend more time on the art of medicine, directly working with patients.   David explains, "So, Regard with real-time clinical artificial intelligence software, is helping clinicians propose the right diagnosis and information while they're working in the chart. Our mission is to make patient care as clear as possible. At the same time, we make sure that the doctors are getting the support they need so they can better support the patient. The charts of patients are getting bigger and bigger every year because more and more data is going into the charts. And as that happens, the really important thing that we as physicians need to find is diluted." "Some research even suggests that maybe doctors are going to see 3% of the data that comes in in the chart when a patient comes into the hospital. As the physician, I'm trying to understand a patient's clinical story with only having access to three pages. Our goal is for artificial intelligence to find important information in that deep sea of data so the treatment team can make better decisions. Maybe you can correct the documentation. What that means is the physician is doing all the work in their natural workflow. We're not having to do prep work during downtime at home, and we're not trying to wrap up notes at night. We need the documentation to be done proactively in a way that is as accurate as possible for the patient at the time of care." #Regard #HealthcareAI #DigitalHealth #MedicalTechnology #PatientCare #HealthTech #AIinMedicine #ClinicalDocumentation #HealthcareInnovation #MedicalAI #PhysicianSupport Regard.com Download the transcript here

Dr. David Kirk, Chief Medical Officer at Regard, discusses the role and benefits of real-time clinical AI to help clinicians navigate patient charts and find critical information to prevent medication management errors and misdiagnoses. The Regard platform can also generate proactive documentation, allowing physicians to complete their documentation more accurately and efficiently, reducing note-bloat and the need for after-hours charting. One key goal of using AI is to free physicians to spend more time on the art of medicine, directly working with patients.   David explains, "So, Regard with real-time clinical artificial intelligence software, is helping clinicians propose the right diagnosis and information while they're working in the chart. Our mission is to make patient care as clear as possible. At the same time, we make sure that the doctors are getting the support they need so they can better support the patient. The charts of patients are getting bigger and bigger every year because more and more data is going into the charts. And as that happens, the really important thing that we as physicians need to find is diluted." "Some research even suggests that maybe doctors are going to see 3% of the data that comes in in the chart when a patient comes into the hospital. As the physician, I'm trying to understand a patient's clinical story with only having access to three pages. Our goal is for artificial intelligence to find important information in that deep sea of data so the treatment team can make better decisions. Maybe you can correct the documentation. What that means is the physician is doing all the work in their natural workflow. We're not having to do prep work during downtime at home, and we're not trying to wrap up notes at night. We need the documentation to be done proactively in a way that is as accurate as possible for the patient at the time of care." #Regard #HealthcareAI #DigitalHealth #MedicalTechnology #PatientCare #HealthTech #AIinMedicine #ClinicalDocumentation #HealthcareInnovation #MedicalAI #PhysicianSupport Regard.com Listen to the podcast here

You can't delegate your longevity to a system that only gets paid when you're sick. In this episode of The Game Changing Attorney Podcast, Michael Mogill sits down with Dr. Bill Kapp, Chief Medical Officer and co-founder of Fountain Life, to explore the cutting edge of longevity science. Dr. Kapp reveals how creating a comprehensive digital twin with 250 gigabytes of personalized health data can detect fatal conditions 20 to 30 years before symptoms appear, why your family doctor is 17 to 20 years behind the latest technology, and how exponential innovations from gene editing to AI-powered diagnostics are reshaping what's possible for extending your healthspan. This conversation cuts through the influencer noise in the longevity space to focus on data-driven approaches backed by science, not hype. Here's what you'll learn: How full-body MRI scans with 10,000 slices and whole genome sequencing create a complete digital twin that enables personalized optimization Why muscle mass is the number one predictor of disease-free longevity and how lifting heavy outweighs everything else you can do Why you need to become the CEO of your own health and stop delegating your longevity to a broken medical system What you don't measure, you can't manage. It's time to become the CEO of your own health. ---- Show Notes: 02:39 – What Fountain Life is and the paradigm shift from symptom-based to proactive care. 12:13 – The comprehensive assessment: what gets measured and why it matters. 16:48 – The real risk of waiting and the airplane maintenance analogy. 20:01 – Genetics versus lifestyle: what's actually in your control. 26:01 – Making longevity technology accessible and what's coming next. 30:34 – Beyond detection: optimizing cellular health, hormones, and mitochondrial function. 41:29 – Longevity escape velocity and whether we can reverse aging in our lifetime. 44:06 – High-performance aging: why 80 doesn't have to mean slowing down. 45:45 – The top 3 takeaways: baseline testing, sleep optimization, and lifting heavy. ---- Links & Resources: Fountain Life Dr. Bill Kapp Tony Robbins Dr. Peter Diamandis Dr. Bob Hariri Why We Sleep by Dr. Matthew Walker ---- Do you love this podcast and want to see more game changing content? Subscribe to our YouTube channel. ---- Past guests on The Game Changing Attorney Podcast include David Goggins, John Morgan, Alex Hormozi, Randi McGinn, Kim Scott, Chris Voss, Kevin O'Leary, Laura Wasser, John Maxwell, Mark Lanier, Robert Greene, and many more. ---- If you enjoyed this episode, you may also like: 396. Why High Performers Can't Afford to Ignore Wellness with Dr. Taz Bhatia 283. Marcus Filly — Fitness Secrets for Professional Success 41. Dave Asprey —Becoming Bulletproof: Living Your Longest and Healthiest Life

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about Rev. Jesse Jackson being diagnosed with a rare neurological disorder, colorectal cancer now being the leading cause of cancer death in people under 50, and how concerned we should be about the rise in measles cases.

Dr. Kim Dennis brings a deeply integrative and courageous voice to the conversation on eating disorders, food addiction, trauma, and recovery. As a board-certified psychiatrist and the Co-Founder, CEO, and Chief Medical Officer of SunCloud Health (https://suncloudhealth.com/) she has spent more than two decades treating complex, co-occurring conditions—while also drawing from her own lived experience in long-term recovery from alcohol use disorder, bulimia, and food addiction. Dr. Dennis believes recovery must address the whole person: biological, psychological, social, and spiritual—not just symptoms or weight. A central theme of this episode is what happens when treatment doesn't work. Dr. Dennis points to a sobering reality: 30–50% of people with eating disorders do not respond to gold-standard treatments, often leaving patients believing they are broken. She challenges that narrative and argues that food addiction—particularly addiction to sugar and ultra-processed foods—is a critical and often dismissed missing piece. Drawing parallels to Big Tobacco, she explains how corporate influence, stigma, and lack of diagnostic legitimacy have delayed research funding, insurance coverage, and effective treatment, despite growing neurobiological evidence involving dopamine reward pathways, craving, withdrawal, and continued use despite harm. Dr. Dennis approaches every patient through a trauma-informed lens, emphasizing that all eating disorders and food addiction exist on a continuum shaped by disrupted safety, neglect, or adversity—what she describes as both “big T” and “little t” trauma. Rather than separating behavior from biology, she explains how trauma alters reward systems and coping mechanisms, making food a powerful regulator of emotion and survival. Her model centers on patient-led collaboration, clinical humility, and a strong therapeutic alliance—meeting people exactly where they are, without leaving them there. The conversation also explores some of the most debated issues in the field, including harm reduction versus abstinence, the eating-disorder community's resistance to food addiction, and the expanding use of GLP-1 medications. Dr. Dennis stresses that abstinence is a “tricky word” that must be defined clinically and individually—not ideologically—and that medications may have a place when used thoughtfully, transparently, and alongside comprehensive care. She closes with a message of hope: recovery is not about weight or perfection, lives do get bigger, and no one should stop seeking answers simply because one approach failed.      #eatingdisorderrecovery  #healthyliving  #obesity  #MAHA    Dr. Nicole Avena (https://www.instagram.com/drnicoleavena/?hl=en) #ashleygearhardt #foodaddiction #ultraprocessed #addictionscience  #foodfreedom

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about Rev. Jesse Jackson being diagnosed with a rare neurological disorder, colorectal cancer now being the leading cause of cancer death in people under 50, and how concerned we should be about the rise in measles cases.

Dr. Jim Adams, Chief Medical Officer of Northwestern Medicine, joins Wendy Snyder, filling in for Lisa Dent, to discuss several health topics. He shares some information about colorectal cancer and its warning signs, whether or not people who have gotten the measles vaccine need a booster, and some lifestyles changes people can make to help reduce their […]

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about Rev. Jesse Jackson being diagnosed with a rare neurological disorder, colorectal cancer now being the leading cause of cancer death in people under 50, and how concerned we should be about the rise in measles cases.

Dr. Frank Peacock and Dr. Damon R. Kuehl join BioTalk for a focused discussion on one of emergency medicine's most persistent challenges: accurately diagnosing and predicting outcomes in mild traumatic brain injury. As Scientific Advisory Board members for BrainBox Solutions, Inc., they walk through what happens when a patient presents to the emergency department after a fall or sports injury and why current tools, including CT scans, often leave clinicians without clear answers. The conversation explores the gap between a "normal" scan and ongoing symptoms, and what missed or uncertain diagnoses can mean for patients weeks later.   Dr. Peacock outlines the HeadSMART II study and explains why combining blood biomarkers with neurocognitive testing provides a more complete assessment than biology alone. Dr. Kuehl discusses how multi-modal data, integrated through artificial intelligence, can generate an objective score to support real-time clinical decision-making and help identify patients at risk for persistent symptoms. The episode also highlights BrainBox's leadership, including CEO Donna Edmonds, a member of the BioHealth Innovation Board of Directors, and the company's role in advancing objective mTBI testing.   Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).   Dr. W. Frank Peacock IV is Professor of Emergency Medicine at Baylor College of Medicine. Chief Medical Officer at AseptiScope, and the founder of both a contract research organization called Comprehensive Research Associates, LLC and a medical education company named Emergencies in Medicine, LLC. Dr. Peacock received his medical degree from Wayne State University Medical School and completed his Emergency Medicine training at William Beaumont Hospital. He has >900 peer reviewed publications and is also the co-editor of multiple medical textbooks on heart failure, acute coronary syndromes, and traumatic brain injury.   Dr. Damon R. Kuehl is the Vice Chair of Research and Academic Affairs and Professor in the Department of Emergency Medicine at Virginia Tech, School of Medicine. He completed Medical School at University of Minnesota Medical School and his Emergency Medicine Residency at Stanford University. He has also completed residencies in Preventive Medicine and a Research Fellowship in the Center for Policy and Research in Emergency Medicine, at Oregon Health and Science University. Dr. Kuehl's research primarily focuses on diagnostic and prognostic uncertainty in brain injury. He is a lead investigator for HeadSMART II and for HeadSMART Geriatrics, a NINDS funded 3 year study to develop a diagnostic tool for head trauma in older adults.  He is the founder of the Carilion Brain Injury Center and also an investigator with the Virginia Tech Center for Biomechanics studying the boundary conditions associated with injuries in older adult falls.

Dennis P.H. Mihale, MD MBA CHCQM, is an ER physician, healthcare executive and chief medical officer who has been delivering care for over 35 years. He currently serves as Chief Medical Officer at Upward Health and is an Assistant Professor at University of South Florida Medical School. Prior to joining Upward Health, he served as the Chief Medical Officer of Consolidated Health Plan, where he was responsible for developing the medical management strategy and creating a Patient Centered Medical Home strategy. He has also served as the CMS Physician Champion for ICD-10 in Florida, founded and led two managed care companies and has served as Chief Medical Officer or Medical Director to more than 15 companies. Denniss biomedical and healthcare technology experience includes working with the IBM Watson Center, NASAs Technology Transfer Team, SMRxT and PatientKeeper. He serves on the advisory boards for Datacys and Revasurrant, and other healthcare technology companies. Dennis received a B.S. in Aerospace Engineering from SUNY Buffalo, an M.D. from the University of Miami School of Medicine and an M.B.A. from the University of South Florida. He retired as a Major from the US Army Reserve MC. His awards include CEO of the Year: Tampa Bay Forum; Entrepreneur of the Year: USF College of Business Administration; Physician Business Leader of the Year: Medical Business Journal and is a Fellow of the National Science Foundation.See omnystudio.com/listener for privacy information.

Dennis P.H. Mihale, MD MBA CHCQM, is an ER physician, healthcare executive and chief medical officer who has been delivering care for over 35 years. He currently serves as Chief Medical Officer at Upward Health and is an Assistant Professor at University of South Florida Medical School. Prior to joining Upward Health, he served as the Chief Medical Officer of Consolidated Health Plan, where he was responsible for developing the medical management strategy and creating a Patient Centered Medical Home strategy. He has also served as the CMS Physician Champion for ICD-10 in Florida, founded and led two managed care companies and has served as Chief Medical Officer or Medical Director to more than 15 companies. Denniss biomedical and healthcare technology experience includes working with the IBM Watson Center, NASAs Technology Transfer Team, SMRxT and PatientKeeper. He serves on the advisory boards for Datacys and Revasurrant, and other healthcare technology companies. Dennis received a B.S. in Aerospace Engineering from SUNY Buffalo, an M.D. from the University of Miami School of Medicine and an M.B.A. from the University of South Florida. He retired as a Major from the US Army Reserve MC. His awards include CEO of the Year: Tampa Bay Forum; Entrepreneur of the Year: USF College of Business Administration; Physician Business Leader of the Year: Medical Business Journal and is a Fellow of the National Science Foundation.See omnystudio.com/listener for privacy information.

Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to discuss the importance of screening for colorectal cancer and why doctors aren’t agreeing when it comes to diagnosing Alzheimer’s. He also talks about healthy heart habits, foods than can help lower blood pressure, and how your brain functions when you don’t […]

In this episode, Thomas Graf, MD, Chief Medical Officer for Florida Blue, part of GuideWell, shares how the health plan is improving cancer care through a high-touch, tech-enabled navigation program for Medicare Advantage members. He discusses reducing variation, closing gaps between diagnosis and treatment, and achieving better outcomes, higher satisfaction, and lower costs by centering care around the patient experience.

Sometimes, I see a book and think, "Did the author just decide to write that especially for me???"  Okay, I know Heather Tabers didn't write Books & Battlefields just for me, but listen in and learn why she did--and a lot more! note: links may be affiliate links that provide me with a small commission at no extra expense to you.  Loved chatting with Heather about this book, particularly since it's WWI set in the US!  That doesn't happen often. Also, I loved that she wrote the sort of "love triangle" that actually makes sense.  I also loved seeing how the Victory Book Campaigns could've been sparked by those that happened in WWI! Books & Battlefields  by Heather Tabers A spirited librarian with a guarded heart. A haunted surgeon battling the past. A quiet deputy who never stopped hoping. Isabella Pearson isn't looking for love—only a way to serve. In 1917, she leaves her privileged Denver life behind to volunteer as a librarian at Camp Sheridan, Alabama. With a suitcase full of books and a heart determined to remain independent, she never expects to find herself being pursued by two men: Nathaniel, her brother's steadfast best friend, and Byron, the brooding Chief Medical Officer who makes her pulse race for all the wrong reasons. Major Byron McDaniel has buried his heart with his late wife and plans to keep it that way. Yet Isabella's courage and compassion rattle the walls he's so carefully built. Meanwhile, Nathaniel Steele has followed Isabella to Alabama with hopes of finally winning the heart he's long treasured in silence. But as tensions rise at Camp Sheridan—with a suspicious fire, a string of accidents, and whispers of sabotage—Isabella must navigate more than just her feelings. When loyalty, love, and liberty hang in the balance, will she trust her heart—or her instincts?  Learn more about Heather on her WEBSITE and follow on GoodReads and BookBub. Like to listen on the go? You can find Because Fiction Podcast at: Apple Castbox Google Play Libsyn RSS Spotify Amazon and more!

Join Our Medical Device Sales Program: https://click.newtomedicaldevicesales.com/yt-431If you're new to my channel, my name is Jacob McLaughlin. I'm the founder of New to Medical Device Sales, an exclusive training program designed to help people break into the competitive field of medical device sales. Our average person lands a six-figure role in just 9.5 weeks, earning $113,760 annually. With thousands of success stories from candidates with all kinds of backgrounds, our program equips you with the tools to succeed in this industry.4 years ago I moved out to Arizona not knowing anyone and had $1200 to my name.I came to this exact spot to journal and share how excited I was to be starting my journey in life.Last night I took time to reflect over the past 4 years. It's truly amazing how you can change your life in such a small amount of time.My take aways:1. Go after your dream because even if it doesn't workout like you thought it would, it will bring your right where you're suppose to be.2. Believe in yourself. Nobody is going to believe in you as much as you will, know that good things will happen.3. Change is inevitable. Change is going to happen so you can either accept it and keep moving forward or not.Please bet on yourself and go after your dreams because your life can be better than you ever thought it could be if you do

Behind every public health response are two make-or-break factors: the people doing the work and the systems that help them work together.  First, Shirley Orr, Executive Director of the Association of Public Health Nurses discusses the Public Health Nursing Workforce Learning Lab Series Session 5 with insights from PHWINS, the nation's only survey of the state and local public health workforce, which reached nearly 50,000 professionals. The data paints a detailed picture of who makes up today's workforce, including an influx of younger staff, persistent leadership diversity gaps, and ongoing concerns about burnout and morale. Later, Dr. Lisa Villarroel, Chief Medical Officer for Public Health of the Arizona Department of Health Services shows us what happens when that workforce is connected in real time. Arizona's Statewide Healthcare Collaborative Forum, a simple monthly virtual call during respiratory season, brings EMS, hospitals, post-acute care, and public health leaders together to review virus trends, hospital capacity, ED diversion, and emerging challenges. Born from pandemic lessons, the forum has led to tangible results: resolving EMS transport delays, sparking regional hospital alliances, rethinking masking policies, and aligning state data with frontline reality.Meeting Home PageMeeting Home Page

Have you heard about the DUTCH test or urine testing for hormones , but when you saw the price you were shocked? You hear that it's important, but not sure if it's worth the price and are looking for alternatives. Then this episode is for you. Today I'm sitting down with my biohacking buddie Dr Amy Killen, who is a leader in women's health, regenerative medicine and longevity, and just spent six months combing through every study she could find on estrogen metabolites and hormone testing We cover What 22+ studies actually show about estrogen metabolites and breast cancer If DUTCH testing is helpful or unnecessary Labs that truly matter for longevity Which tests can help time HRT or track menopause onset The strongest lifestyle habits for extending our healthspan What's the number one treatment for skin health in menopause The top three longevity habits for women And so much more   Amy B. Killen, M.D., specializes in women's longevity–specifically hormone optimization and regenerative medicine–using research-backed and evidence-based interventions so women can thrive during their Queen Phase™.  She's a board-certified former Emergency Medicine physician who has dedicated the past dozen years to honing her expertise in health optimization, integrating treatments like pioneering stem cell therapies, bioidentical hormones, and peptides with personalized lifestyle strategies and technology-driven decision-making.  As an entrepreneur, she co-founded and now serves as Chief Medical Officer of Humanaut Health, a longevity clinic franchise. She also founded and remains immersed in the Human Optimization Project (HOP), a female-focused supplement company that bridges innovative medical treatments with accessible wellness solutions.  She shares her expertise and reaches audiences through educational content creation on her website and Substack, international speaking engagements, podcasts, and various media outlets. Dr. Killen earned her bachelor's degree in Biomedical Science from Texas A&M University and then her doctor of medicine degree from UT Southwestern Medical School. She became Chief Resident while completing an Emergency Medicine residency at the University of Arizona. She lives in Salt Lake City, Utah, with her family of five. Disclaimer: This is not meant to be medical advice. Dr. Amy is a doctor, but not your doctor.   Supplements: www.hopbox.life , Clinics: www.humanauthealth.com Discount code ZORA Contact Dr. Amy Killen: Social:  @dr.amybkillen,  @humanauthealth @hopboxlife  Substack: The Good, Bad and Ugly of Estrogen Metabolite Testing https://dramybkillen.substack.com/p/the-good-bad-and-ugly-of-estrogen Website: www.dramykillen.com  Healthcare: www.humanauthealth.com  Supplements: www.hopbox.life 10% off code ZORA   Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com - https://trysuji.com Try OneSkin skincare with code ZORA for 15% off https://oneskin.pxf.io/c/3974954/2885171/31050   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  For transparency: Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

Join host Eve Cunningham, MD, Chief Medical Officer at Cadence, in conversation with Dave Newman, MD, Chief Medical Officer of Virtual Care at Sanford Health.Sanford Health is the largest rural health system in the United States, serving more than two million patients across a multi-state region in the upper Midwest. In this episode, Eve and Dave explore what rural healthcare reveals about innovation that actually scales, and why some of the most advanced care models in the country are being built far from major urban centers.Their conversation focuses on:Why rural health systems are often the best environments for scaling innovation How Sanford has leveraged virtual care to extend specialist access across vast geographies and address workforce shortagesWhat it looks like to lead digital transformation while continuing to practice medicine, and why staying close to the bedside mattersHow technologies like ambient documentation and AI-enabled workflows are changing clinician experience and patient connectionWhy innovation without workforce strategy fails, and what sustainable virtual care actually requiresThe myths the industry still gets wrong about rural patients, technology adoption, and accessPatient examples in this episode are anonymized or illustrative. Metrics discussed may be internal. For more information on Cadence, visit https://www.cadence.care/

Our guest: Kat McGraw MD, FHM, CPE, Chief Medical Officer at Guava Health. Guava's mission is to empower people to understand and improve their health. Learn More at: https://guavahealth.com/

[SPONSORED] AI scribes have quickly become part of the daily routine for many clinicians. The question now is whether that momentum keeps building or slows as attention shifts to other operational priorities.In this interview, Dr. Michael Blackman, Chief Medical Officer at Greenway Health, talks about what he is seeing on the clinical front one year after launching their ambient scribe. He shares why he thinks this approach to documentation is here to stay and why he views it as the first step rather than the finished product. He also touches on unexpected moments from early use and what he believes is possible next.Do you think the pace of AI innovation will slow down or speed up or stay the same in the year ahead? Share your thoughts below.

In this episode, Dr. Sidney H. Raymond, Chief Medical Officer at Ochsner Health Network, discusses leading population health across more than 600,000 lives and advancing value based care beyond contract boundaries. He shares how care model redesign, prevention focused strategies, digital health, and patient centered culture are driving measurable gains in quality, cost, and care coordination across diverse communities.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Dr. Sahasranam: Emotional intelligence.Diabetes education saves lives, yet only 5 to 7 percent of people with diabetes ever receive it. This startling gap in care is the driving force behind My Diabetes Tutor, a telehealth platform founded by Dr. Prem Sahasranam. His mission? To make diabetes education accessible to everyone, regardless of geography or socioeconomic barriers.Dr. Sahasranam, a board-certified endocrinologist with nearly two decades of experience, explained how critical education is in diabetes management: “Studies have shown that just going through diabetes education reduces A1C by 0.73 points. At our program, our outcomes are two times better than the national average.” With over 9,000 patients served, My Diabetes Tutor consistently delivers remarkable results, achieving an average A1C reduction of 1.6 points—enough to significantly lower complications and mortality rates.The idea for My Diabetes Tutor was born out of necessity. Dr. Sahasranam shared a story about how two full-time diabetes educators in his rural California practice helped patients achieve exceptional outcomes. When they retired in 2018, he struggled to recruit replacements, a problem endemic to underserved areas. “I decided to build a telehealth program,” he said. “My goal was to solve an access issue and deliver diabetes education to people, irrespective of their zip code or language.”My Diabetes Tutor provides nationally accredited virtual diabetes education, covering medical nutrition therapy, continuous glucose monitoring, insulin pump training, and more. The platform recently launched the first-ever pediatric diabetes education program, a groundbreaking step toward addressing the needs of young patients.Dr. Sahasranam's vision extends beyond patient outcomes to include investor participation. My Diabetes Tutor is currently raising capital through a regulated crowdfunding campaign on StartEngine. “I want investors to own a piece of our growth and be part of our journey,” he said. The company generated over $2 million in revenue last year with a 61 percent gross margin, demonstrating both impact and financial viability.Dr. Sahasranam's work is not just about business; it's a mission to transform lives. By breaking down barriers to education, he's giving people the tools to manage their diabetes effectively, live healthier lives, and reduce complications.For those looking to make a difference—or simply to invest in a business delivering measurable impact—My Diabetes Tutor offers a unique opportunity.tl;dr:Dr. Prem Sahasranam founded My Diabetes Tutor to provide virtual education for diabetes management.The program addresses barriers to care in underserved communities by delivering telehealth services nationwide.My Diabetes Tutor achieves outcomes twice as effective as national averages in reducing A1C levels.The company generated over $2 million in 2025 and is raising capital via StartEngine crowdfunding.Prem credits emotional intelligence as his superpower, driving his mission to revolutionize diabetes care.How to Develop Emotional Intelligence As a SuperpowerDr. Prem describes his superpower as emotional intelligence, honed through years of experience as a board-certified endocrinologist. He explained, “Most health systems focus on the biology of the disease and fail to address the human part.” By understanding the emotional and practical needs of patients, Prem has created innovative solutions to improve access to diabetes education. He added, “I learned from my experience and built the right team, content, and technology to bring in diabetes education, easily accessible for patients.”Prem shared a pivotal story of a patient who had been struggling to control their diabetes despite receiving appropriate medications. The patient hesitated to make a two-hour drive to see Prem but eventually visited his practice and met with a diabetes educator. Without altering the patient's medications, the educator provided tailored guidance that helped the patient manage their condition. This experience inspired Prem to create My Diabetes Tutor, ensuring patients could access life-changing education from their own homes.Tips for Developing Emotional Intelligence:Reflect on past experiences to identify unmet needs and learn from them.Stay aware of the human challenges behind systemic issues.Focus on creating solutions that address both emotional and practical barriers.Build strong, empathetic teams that align with your mission.By following Dr. Prem's example and advice, you can make emotional intelligence a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Get Your Copy!Guest ProfileDr. Prem Sahasranam (he/him):Founder, CEO, and Chief Medical Officer, My Diabetes Tutor (MDT)About My Diabetes Tutor (MDT): My Diabetes Tutor (MDT) is an ADCES-accredited telehealth service that provides comprehensive Diabetes Self-Management Education and Support (DSMES) via virtual, 1-on-1 sessions with Certified Diabetes Care and Education Specialists (CDCES). We bridge the gap for the 93% of eligible patients who currently do not utilize DSMES due to access barriers. We accept Medicare, Medicaid, and most private insurance (often with $0 out-of-pocket for patients). Participants achieve an average 1.6 pt reduction in A1C, 2x the national average for diabetes education.Website: mydiabetestutor.comCompany Facebook Page: facebook.com/mydiabetestutorInstagram Handle: @mydiabetestutor_Other URL: startengine.com/offering/my-diabetes-healthBiographical Information: Prem Sahasranam, MD (Dr. Sahas) is a Board-Certified Endocrinologist with over 20 years of clinical experience. He founded My Diabetes Tutor in 2019 to address the critical shortage of specialists in rural “care deserts”. A graduate of Madras Medical College with post-graduate training at Cornell University's Weill Medical College, he is currently an Assistant Clinical Professor at Loma Linda University and a dedicated advocate for health equity.LinkedIn Profile: linkedin.com/in/prem-sahasranam-ba10077Personal Facebook Profile: facebook.com/PremsahasranamThe Super Crowd, Inc., a public benefit corporation, is proud to have been named a finalist in the media category of the impact-focused, global Bold Awards.Support Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include rHealth, and Make Money with Impact Crowdfunding. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Nick Degnan, Unlimit Ventures | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on February 17th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details. Upgrade to Impact Membership today!SuperCrowdHour February: This month, Devin Thorpe will be digging deep into my core finance expertise to share guidance on projections and financial statements. We're calling it “Show Me the Numbers: Building Trust with Financial Clarity.” Register free to get all the details. February 18th at Noon ET/9:00 PT.Superpowers for Good Live Pitch: The top-raising Reg CF campaign of 2025 won the June 2025 Superpowers for Good Live Pitch. We're taking applications for the March 17, 2026, Live Pitch now. There is no fee to apply and no fee to pitch if selected! Apply here now!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

In this episode of the progesterone series, Dr. Brendan McCarthy — Chief Medical Officer of Protea Medical Center in Tempe, Arizona — explores the often misunderstood relationship between progesterone, estrogen, and breast health. For decades, women have been taught to fear their breasts and fear hormones. While awareness matters, fear is disempowering — and it has left many women confused about what's actually happening in their bodies. In this episode, we discuss: Why breast tissue is dynamic, not static How estrogen stimulates growth and progesterone restores balance The role of progesterone in breast tissue maturation and architecture Why dense or fibrocystic breasts often reflect unopposed estrogen How restoring ovulation and progesterone can reduce breast pain and density in some women The difference between natural progesterone vs synthetic progestins Where the fear around progesterone and breast cancer really came from Progesterone is not something to fear — it is a hormone of organization, balance, and maturation. Understanding how it works allows women to approach breast health with clarity instead of anxiety.

2.11.26 - Dr. Ravi Johar - Chief Medical Officer at United HealthCare by

In this episode of Denatured, Jennifer C. Smith-Parker speaks with Dr. Rob Monroe, Vice President and Chief Scientific Officer of Oncology at Danaher Corporation and Chief Medical Officer at Leica Biosystems, and Jennifer Fakish, Vice President and Franchise Head of Oncology at Danaher Corporation. We'll be discussing how antibody drug conjugates (ADCs) are transforming cancer care and with AI-powered pathology, doctors can now measure her HER2 more precisely to match patients with the best treatments. HostJennifer Smith-Parker, Director of Insights, BioSpaceGuestsDr. Rob Monroe, Vice President and Chief Scientific Officer, Oncology, Danaher Corporation; Chief Medical Officer, Leica BiosystemsJennifer Faikish, Vice President and Franchise Head, Oncology, Danaher CorporationDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Medicare for all. Not socialized medicine, just a single, government-run system that provides healthcare.  Is it possible? Or even viable? Our guest this week on the Creating a New Healthcare podcast believes so. In fact, he sees it as the only way to ultimately address the affordability problem with healthcare, particularly for high cost conditions like cancer. In today's episode, we talk with Dr. Troy Brennan about his book, The Transformation of American Health Insurance: On the Path to Medicare for All, and why a single payer, government system is needed, and how the changes the current administration has made to our public health systems is taking us backwards, not forward. Troyen Brennan is an Adjunct Professor at Harvard Chan School of Public Health.  He was formerly the Executive Vice President and Chief Medical Officer for CVS Health and Aetna. Before that, he was the President of the Brigham and Women's Physician Organization and Professor of Medicine at Harvard Medical School.  He was also Professor of Law and Public Health at the Harvard Chan School of Public Health.  Brennan was formerly the Chair of the American Board of Internal Medicine and is a member of the National Academy of Medicine. He has published six books and over 600 articles. 

(February 11, 2026) Nancy Guthrie: Video released, person detained and released. Los Angeles and Long Beach among the least affordable cities in the world. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany joins the show from Milan, Italy and the Winter Olympics where his AirBnB had… BED BUGS!See omnystudio.com/listener for privacy information.

In this episode, Dr. Andy Cutler talks with Dr. Tim Wilens about enduring myths surrounding ADHD diagnosis and treatment, beginning with why misconceptions about overdiagnosis and misuse continue to shape clinical hesitation. They explore common misunderstandings about ADHD medications—including stimulants versus non-stimulants, concerns about diversion, personality changes, and long-term safety—and contrast stigma-driven narratives with the clinical evidence. The conversation equips clinicians with practical, evidence-based strategies to address patient fears, counter misinformation, and make thoughtful, individualized treatment decisions.  Timothy Wilens, MD, is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. He is the MGH Trustees Chair in Addiction Medicine and a professor of psychiatry at Harvard Medical School. Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders, embedded health care models, and the pharmacotherapy of ADHD across the lifespan.   Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Save $100 on registration for 2026 NEI Spring Congress with code NEIPOD26  Register today at nei.global/spring  Never miss an episode!

Is Artificial Intelligence actually helping cancer patients, or is it just noise? In this episode of The Patient From Hell, Samira sits down with Dr. Shadi Nabhan to separate the Hype from the Reality in 2026.We discuss the massive evolution in oncology—from the "library days" of 1995 to the AI-driven diagnostics of today. Dr. Shadi shares his "Airport Analogy" for navigating a cancer diagnosis, offers a life-changing reframe on how we view advanced disease (it's not just "curable" vs. "terminal"—it can be "controllable"), and gives his #1 piece of advice for selecting a medical team that will actually show up for you when things get hard.Key Topics Discussed:AI in 2026: How doctors use AI to simplify complex terms like CAR T-cell therapy and why patients need to "trust but verify" AI-generated medical advice.The "Controllable" Reframe: Why treating metastatic cancer like diabetes or hypertension changes the patient experience.Navigating the "Airport": Why the healthcare system feels like being dropped in a foreign airport without a map.Advice for the Industry: What Healthcare Systems and Pharma companies need to change right now regarding clinical trials and drug pricing.About Today's Guest Dr. Chadi Nabhan:Dr. Chadi Nabhan is a board-certified hematologist, oncologist, and the Chief Medical Officer at Ryght, Inc., where he leads the integration of Generative AI into clinical research to accelerate the delivery of lifesaving therapies. With a career spanning leadership roles at Caris Life Sciences and the University of Chicago, Dr. Nabhan is a prolific researcher with over 300 publications and a prominent author whose work focuses on the intersection of medicine, justice, and technology.AI Visionary: Leading the charge in using AI to optimize clinical trials and patient outcomes.Expert Clinician: Trained at Northwestern and Harvard, with decades of experience in malignant hematology.Renowned Author: Published three books with Johns Hopkins University Press, including The Cancer Journey and the forthcoming AI and Cancer Care (2026).Podcast Host: Voice of the popular weekly series Healthcare Unfiltered.Quotes from the Episode:"We cure more patients than we have ever dreamt of... Women who are affected by breast cancer today are more likely to be completely cured." "Availability is key. Are they going to really pick up the phone and talk to you when you need them?"00:00 - The reality of the cancer journey (It's not smooth sailing)01:00 - Intro: Dr. Shadi Nabhan & The Fun Factor01:25 - AI in Healthcare: Hype, Hope, and Reality04:15 - How doctors use AI to explain complex therapies06:38 - Warning for patients using AI: "Garbage in, Garbage out"08:45 - The Evolution of Medicine: 1995 vs. 202613:00 - The "Airport Analogy": Why patients feel lost17:30 - MUST WATCH: Reframing "Terminal" cancer as "Controllable"21:30 - Advice for Healthcare Leaders: Agility & Patient Involvement23:50 - Advice for Pharma: Drug Pricing & Accelerating Innovation26:00 - The #1 criteria for picking your medical team28:18 - The importance of Second Opinions28:50 - What to expect in late 2026: AI in Cancer Care Book

Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons.  The goal is not to cure the underlying cause of the disease, but to restore motor function and reverse the disease's progression. Initial clinical focus was on patients with moderate to moderate-severe idiopathic Parkinson's, showing efficacy and safety, leading to expanding the study to include earlier-stage and familial forms of the disease. Howard explains, "Kenai was formed about three and a half years ago, and the intention is to develop a cellular product, which means that what is manufactured will be eligible in the right patient groups who have a diagnosis of Parkinson's to be placed into the brain. And consequent to its placement, the cells will then form new circuits, dopamine circuits that are lost owing to the disease diagnosis that will have occurred years earlier." "The induced pluripotent stem cell approach is one we favor for several reasons. The nature of what then becomes the IPSC, as we like to call it, starts with a normal human volunteer whose medical history is very detailed and does not contain any familial personal history of neurodegeneration. That cell then undergoes a process called reprogramming. And in our case, it's done with a slightly different approach than many others. And the reprogramming effectively creates a cell that is pluripotent, meaning it can become any cell of the body. That's when it is designated as an induced pluripotent stem cell."  #KenaiTherapeutics #ParkinsonsDisease #CellTherapy #StemCells #Neuroscience #MedicalInnovation #ClinicalTrials #RegenerativeMedicine #Biotechnology #BioTech #AdvancedBiologics #NeurologicalDisorders #Neurology #DrugDevelopment KenaiTx.com Download the transcript here  

Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons.  The goal is not to cure the underlying cause of the disease, but to restore motor function and reverse the disease's progression. Initial clinical focus was on patients with moderate to moderate-severe idiopathic Parkinson's, showing efficacy and safety, leading to expanding the study to include earlier-stage and familial forms of the disease. Howard explains, "Kenai was formed about three and a half years ago, and the intention is to develop a cellular product, which means that what is manufactured will be eligible in the right patient groups who have a diagnosis of Parkinson's to be placed into the brain. And consequent to its placement, the cells will then form new circuits, dopamine circuits that are lost owing to the disease diagnosis that will have occurred years earlier." "The induced pluripotent stem cell approach is one we favor for several reasons. The nature of what then becomes the IPSC, as we like to call it, starts with a normal human volunteer whose medical history is very detailed and does not contain any familial personal history of neurodegeneration. That cell then undergoes a process called reprogramming. And in our case, it's done with a slightly different approach than many others. And the reprogramming effectively creates a cell that is pluripotent, meaning it can become any cell of the body. That's when it is designated as an induced pluripotent stem cell."  #KenaiTherapeutics #ParkinsonsDisease #CellTherapy #StemCells #Neuroscience #MedicalInnovation #ClinicalTrials #RegenerativeMedicine #Biotechnology #BioTech #AdvancedBiologics #NeurologicalDisorders #Neurology #DrugDevelopment KenaiTx.com Listen to the podcast here  

In this episode, Dr. Sidney H. Raymond, Chief Medical Officer at Ochsner Health Network, discusses leading population health across more than 600,000 lives and advancing value based care beyond contract boundaries. He shares how care model redesign, prevention focused strategies, digital health, and patient centered culture are driving measurable gains in quality, cost, and care coordination across diverse communities.

In this episode, Thomas Graf, MD, Chief Medical Officer for Florida Blue, part of GuideWell, shares how the health plan is improving cancer care through a high-touch, tech-enabled navigation program for Medicare Advantage members. He discusses reducing variation, closing gaps between diagnosis and treatment, and achieving better outcomes, higher satisfaction, and lower costs by centering care around the patient experience.

Patient-centered design is not a nice-to-have in healthcare. It is the key to access, trust, and better outcomes. In this episode, Dr. Justin Coffey, Chief Medical Officer at WorkIt Health, discusses how designing treatment around lived experience can transform substance use care. He explains the philosophy of patients as designers, why immediate access matters in moments of readiness, and how whole-person care better reflects the realities of recovery. The conversation highlights how digital care can reduce stigma, improve engagement, and reach underserved populations, including rural patients and pregnant individuals. Dr. Coffey shares practical examples of how technology, team-based care, and thoughtful design remove barriers while maintaining human connection and explores the future role of AI in supporting care delivery and patient empowerment. Tune in and learn how patient-designed digital care can create more accessible, humane, and effective treatment. Resources: Connect with and follow Dr. Justin Coffey on LinkedIn. Follow Workit Health on LinkedIn and explore their website.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about pacemaker technology, and a new study about coffee intake and dementia risk.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about pacemaker technology, and a new study about coffee intake and dementia risk.

In this episode, Dr. Greg Jones sits down with Dr. Sharon Hausman-Cohen, Chief Medical Officer of IntelliXX DNA, to explore how medical genomics is transforming the way we understand heart disease, brain health, inflammation, and metabolism. Most people think genetics stops at traits like eye color or ancestry. Genomics goes much deeper—analyzing how thousands of genes interact to influence cardiovascular risk, cognitive function, clotting tendencies, nutrient metabolism, and chronic inflammation.Dr. Hausman-Cohen explains why many direct-to-consumer DNA tests fall short, how incomplete interpretation can mislead patients, and why clinician-guided genomic analysis allows for truly personalized care. The conversation also dives into inflammation, methylation, homocysteine, cholesterol myths, caffeine metabolism, mitochondrial health, and women's unique clotting risks.Whether you're trying to reduce your risk of heart disease, improve mental clarity, or understand how your biology responds to diet, supplements, and medications—this episode offers a science-based roadmap for precision health.

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about pacemaker technology, and a new study about coffee intake and dementia risk.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Clinical trials are the gateway to getting life-saving therapies to patients, yet traditional research methods often create barriers that slow progress and limit participation.Our next guest, Dr. Pamela Tenaerts, is tackling this challenge as Chief Medical Officer of Medable.With more than two decades of clinical research experience, including leadership of the Clinical Trials Transformation Initiative, Pamela possesses a unique perspective bridging rigorous science and digital innovation.Driven by a passion to ensure that evidence-based best practices guide how we transform research, Pamela shares Medable's pioneering vision to decentralize clinical trials and meet patients where they are.Join us to discover how Medable's digital platform is accelerating trials across 70 countries, expanding patient access, and getting effective therapies to people faster. Let's go!Episode Highlights:Evidence First: Always research whether a solution actually works before implementing—assumptions can be wrong.One, One, and One: Medable's vision is to start a study in one day, enroll in one day, and complete in one year.Expanding Access: Decentralized trials help rare disease and rural patients participate without traveling to research sites.AI Integration: Medable uses AI to instantly generate patient questionnaires and automate trial workflows.Finding Trials: Patients need easier ways to discover clinical trials that exist for their conditions.About our Guest:Pamela Tenaerts, MD, is Medable's Chief Medical Officer, and aims to drive advancement of decentralized research methodologies with evidence-based best practices. She brings more than two decades of clinical research experience having previously served as Executive Director of the Clinical Trials Transformation Initiative (CTTI), Director of Clinical Programs at Coaxia, Director of the Clinical Research Center at Sarasota Memorial Hospital, and various other research positions. She can be reached at pamela.tenaerts@medable.com.Links Supporting This Episode: Medable Website: CLICK HEREDr. Pamela Tenaerts LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website:

Are you doing "all the right things" for menopause but still feel like your body didn't get the memo? Have you ever wondered why some women suffer longer, harder, and with fewer answers during the menopause transition? Well, sometimes it's down to race and ethnicity.  We cover: Why menopause symptoms last dramatically longer for some women, and what the SWAN Study reveals about race, ethnicity, and biology The foundational "trifecta" every woman needs before hormones can truly work Why basic cholesterol labs often miss real cardiovascular risk in midlife women Which advanced heart tests are most useful, and which are overhyped Where breast cancer screening should really begin, and what to do about the fear of mammograms Dr. Jessica Shepherd is a board-certified gynecologist, menopause specialist, and nationally recognized women's health expert. She is the Chief Medical Officer for Hers and the founder of Sanctum Med + Wellness in Dallas, where she helps women optimize their health. She is the author of Generation M, a book about menopause and longevity. Dr. Shepherd has appeared on Good Morning America, The Today Show, CNN, and many other media outlets. She serves on advisory boards for Women's Health Magazine, Women'sHealth.org, and the Society for Women's Health Research.  Generation M book: https://amzn.to/3Zmsdp1 Contact Dr. Jessica Shepherd: Instagram: https://www.instagram.com/jessicashepherdmd Website: https://www.jessicashepherdmd.com/ Email: hello@jessicashepherdmd.com Modern Meno: https://www.instagram.com/modernmeno/ Sanctum Well: https://www.sanctumwell.com/ Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com - https://trysuji.com Try OneSkin skincare with code ZORA for 15% off https://oneskin.pxf.io/c/3974954/2885171/31050   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

Australian conservationist and television personality Robert Irwin broke the news that the 49ers and Rams will play in the NFL's first Australia game next season at the Melbourne Cricket Ground. Irwin joined "49ers Talk" host Matt Maiocco, with a python in tow, to discuss what NFL fans can expect from the first game down under. Local legends, Giants broadcaster Dave Flemming and 49ers Hall of Fame linebacker Patrick Willis, followed to offer their views on San Francisco's offensive line and linebacking corps, respectively. Willis also shared what motivated him to make it to the NFL, while Flemming offered insight into his first impression of Heisman Trophy winner and College National Champion Fernando Mendoza. Matt then checked in with the NFL's Chief Medical Officer, Dr. Allen Sills, to get to the bottom of the 49ers' injury concerns. Finally, 49ers Hall of Fame wide receiver Jerry Rice stopped by to share how he grew out of his shell in the NFL and discusses what type of wideout the Red and Gold need to acquire for next season.--(8:30) Robert Irwin reveals NFL's first Aussie stop with 49ers-Rams rivalry booked for Melbourne(18:00) Patrick Willis opens up on NFL motivation, Jim Harbaugh's impact, current 49ers linebacking corps(27:00) Giants broadcaster Dave Flemming on Heisman Trophy winner Fernando Mendoza(40:30) NFL Chief Medical Officer Dr. Allen Sills analyzes 49ers' injuries, electrical substation theories(53:30) 49ers legend Jerry Rice identifies type of wide receiver SF needs in 2026 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Have you ever wondered what it was like to be in the room when the first pelvic embolization was performed or how the TIPS procedure was pioneered? Dr. Ernie Ring, a legendary figure from UCSF and a true forefather of Interventional Radiology, joins host Dr. Peder Horner to recount the early days of the specialty. Dr. Ring shares fascinating stories from his training at Massachusetts General Hospital under Dr. Stanley Baum, where he witnessed the birth of transformative techniques using angiographic catheters to treat life-threatening bleeding. --- SYNPOSIS From improvising the use of autologous blood clot and thrombin to stop massive hemorrhages to his pivotal role in developing the TIPS procedure and specialized biliary catheters, Dr. Ring's career is loaded with innovation. The conversation explores the "cowboy" era of IR, the evolution of essential tools like the glide wire, and the critical importance of maintaining a "high-touch" clinical practice in the face of emerging technologies like AI. Dr. Ring also reflects on his later transition into hospital leadership as Chief Medical Officer, where he applied his problem-solving mindset to institutional quality and safety. --- TIMESTAMPS 00:00 - Introduction01:58 - Upbringing from Detroit to Mass Gen 06:55 - Early IR with an Embo Case13:50 - Trailblazing Cases in IR16:17 - Penn and Innovation20:00 - Polarizing Procedures24:13 - IR Device Innovation33:00 - Dotter's Separation from Diagnostics37:30 - Fear Finds Cowboys39:08 - AI and Robotics40:08 - Fun Hobbies